Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Cytovance Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Speed up your program with end-to-end microbial and mammalian biologics development and manufacturing expertise — spanning everything from biosimilars to vaccines.

  2. Novartis Capacity Update April 2025: Large Molecule Development 4/22/2025

    Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.

  3. Samsung Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Leveraging advanced technology, expertise, and flexible capacity, clients can reduce development time and costs while ensuring a smooth transition from clinical to commercial manufacturing.

  4. Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development 4/22/2025

    Explore how world-class contract manufacturing expertise and global capabilities can help accelerate your biologic from development to commercial success.

  5. Leveraging Advanced Technology And Proven Expertise 4/22/2025

    By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

  6. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development 4/22/2025

    Associate Director kojoX and Technology Development, Rasmus Petersen, presents a high-level overview of FDB’s capabilities, its global facilities network, and capacity updates for BIOLOGICS.

  7. Northway Biotech Capacity Update January 2025: Large Molecule Development 1/28/2025

    Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.

  8. Mabion Capacity Update January 2025: Large Molecule Development 1/28/2025

    Go on a virtual tour of our GMP-certified facility, where we uphold our expanded capabilities for large molecule development to the highest standards for clinical and commercial manufacturing.

  9. KBI Biopharma Capacity Update January 2025: Large Molecule Development 1/28/2025

    Follow along as Derek Ryan, Sr. Director of Analytical Development, showcases our high-throughput technology and digital tools for process understanding and optimizing decision-making.

  10. Cytovance Biologics Capacity Update January 2025: Large Molecule Development 1/28/2025

    Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.